Buch, Englisch, 180 Seiten, Previously published in hardcover, Format (B × H): 152 mm x 229 mm, Gewicht: 287 g
Clinical Advances
Buch, Englisch, 180 Seiten, Previously published in hardcover, Format (B × H): 152 mm x 229 mm, Gewicht: 287 g
Reihe: Ernst Schering Foundation Symposium Proceedings
ISBN: 978-3-642-42190-7
Verlag: Springer
This book gives an updated review of the state of the art in regenerative cell therapy in the fields of cardiology, hematology, pediatrics, neurology, orthopedics and infectious diseases. The book emphasizes clinical advances as proof of concept in cell therapy based on the revolutionizing observation that regeneration can occur throughout the body even in highly differentiated organs like the heart and the neuronal system. It provides examples of breakthroughs in the clinical implementation of adult stem cell therapy.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Pädiatrie, Neonatologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Orthopädie, konservativ
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Hämatologie, Transfusionsmedizin
Weitere Infos & Material
Problems and Hopes with Cell Therapy: The Case of Muscular Dystrophy.- Cardiac Myoblasts.- Tissue Engineering, Stem Cells, and Cloning: Current Concepts and Future Trends.- Bone Marrow Cell Therapy for Genetic Disorders of Bone.- Immune-Based Cell Therapy for Acute and Chronic Neurodegeneratlve Disorders.- Mesenchymal Stem Cells for the Treatment of Hematological Malignancies.- Perspectives in Transfusion Medicine for the Ex Vivo Control of Hematopoiesis.- T-Cell Therapies for EBV-Associated Malignancies.- Peptide Vaccination of Myeloid Leukemia.- Hematopoietic Cell Transplantation after Nonmyeloablative Conditioning.
